Funding for this research was provided by:
Nederlandse Organisatie voor Wetenschappelijk Onderzoek (09150181910040)
Received: 3 May 2022
Accepted: 26 July 2022
First Online: 12 September 2022
: The study was approved by the medical ethics committee of Leiden University Medical Centre.
: Not applicable.
: Gisela Terwindt reports consultancy support from Allergan/Abbvie, Lilly, Lundbeck, Novartis, and Teva, and independent support from Dutch Organization for Scientific Research, the Dutch Heart & Brain Foundations, IRRF and Dioraphte. Antoinette MaassenVanDenBrink reports consultancy or industry grant support from Novartis, Lilly and Teva, and independent support from the Dutch Research Council and the Dutch Heart & Brain Foundations. Simone de Vries Lentsch, Ingrid Garrelds and Jan Danser have nothing to disclose.